BioSpace News Archive

Pharm Country

Seelos Therapeutics Doses First Patient in an Open Label Basket Study of SLS-005 in Amyotrophic Lateral Sclerosis in Australia and Provides an Enrollment Update of its Study on the HEALEY ALS Platform

Seelos Therapeutics, Inc. today announced dosing of the first patient in an open-label basket study of SLS-005.

July 18, 2022
·
5 min read
Radialis PET Imager Receives FDA Clearance

Radialis Inc. announces it has received FDA clearance to market the Radialis PET Imager, an advanced organ-targeted positron emission tomography (PET) system, in the United States.

July 18, 2022
·
2 min read
Bio NC

Mycovia Pharmaceuticals Announces U.S. Availability of VIVJOA™ (oteseconazole) Capsules, the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)

VIVJOA is a new option for postmenopausal and permanently infertile women with recurrent vulvovaginal candidiasis (RVVC).

July 18, 2022
·
6 min read
Business

MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy

MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. today announced publication of data from the Phase 1b clinical study of zandelisib, an orally administered investigational phosphatidylinositol 3-kinase delta (“PI3Kδ”) inhibitor.

July 18, 2022
·
10 min read
Business

Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 third quarter ended June 30, 2022, before the opening of the market on Aug. 5, 2022.

July 18, 2022
·
2 min read
Business

Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 3, 2022.

July 18, 2022
·
1 min read
Business

Delcath Systems Announces Private Placement of $5.0 Million

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that it has entered into a securities purchase agreement with certain accredited investors for a private placement transaction (the “Private Placement”).

July 18, 2022
·
5 min read
Lone Star Bio

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Muscle Invasive Bladder Cancer

Natera, Inc. (NASDAQ: NTRA), today announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX) that the Signatera molecular residual disease (MRD) test has met coverage requirements for patients with muscle invasive bladder cancer (MIBC), effective April 19, 2022.

July 18, 2022
·
5 min read
Business

Velodyne Lidar to Report Second Quarter 2022 Financial Results on August 8, 2022

Velodyne Lidar, Inc. (NASDAQ: VLDR, VLDRW), today announced that it will release its second quarter 2022 financial results for the period ended June 30, 2022, on Monday, August 8, 2022, after the market close.

July 18, 2022
·
1 min read
Exactech Launches Significant Update to Equinoxe® Shoulder Preoperative Planning App

Exactech Launches Significant Update to Equinoxe ® Shoulder Preoperative Planning App.

July 18, 2022
·
4 min read